Sesen Bio Inc.

NASDAQ:SESN   3:59:57 PM EDT
1.01
0.00 (0.00%)
Products

Sesen Bio - On Nov 17, FDA Granted Co's Request For A Type A Meeting To Discuss Recommendations Regarding CRL

Published: 11/18/2021 13:27 GMT
Sesen Bio Inc. (SESN) - Sesen Bio - on Nov 17, FDA Granted Co Request for a Type a Meeting to Discuss Recommendations Regarding Crl for Co's Bla for Vicineumtm.
Sesen Bio Inc - Clinical Type a Meeting Has Been Scheduled for December 8, 2021.